Odyssey Pharmaceuticals, Inc.
Records under this name other than patents Odyssey Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Odyssey Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,989,218 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Lapsed on the fee record Ended Aug 2, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 2, 2019 | USPTO record |
| US 7,160,691 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Oct 14, 2018 · USPTO record | Term ended | Term ended Oct 14, 2018 | USPTO record |
| US 6,294,330 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Jul 30, 2018 · USPTO record | Term ended | Term ended Jul 30, 2018 | USPTO record |
| US 6,270,964 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Feb 2, 2018 · USPTO record | Term ended | Term ended Feb 2, 2018 | USPTO record |
| US 6,428,951 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Ended no later than Feb 2, 2018 · USPTO record | Term ended | Ended no later than Feb 2, 2018 | USPTO record |
| US 8,192,944 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Ended no later than Feb 2, 2018 · USPTO record | Term ended | Ended no later than Feb 2, 2018 | USPTO record |
| US 6,897,017 | Vivo library-versus-library selection of optimized protein-protein interactions Formerly held Lapsed on the fee record Ended May 24, 2017 · USPTO record | Lapsed on the fee record | Ended May 24, 2017 | USPTO record |
| US 7,855,167 | In vivo screening of protein-protein interactions with protein-fragment complementation assays Formerly held Lapsed on the fee record Ended Dec 21, 2014 · USPTO record | Lapsed on the fee record | Ended Dec 21, 2014 | USPTO record |
| US 7,125,563 | Sustained release pharmaceutical preparations and methods for producing the same Formerly held Lapsed on the fee record Ended Oct 24, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2010 | USPTO record |
| US 5,661,142 | Anti-emetic composition Term ended Term ended no later than Aug 26, 2017 · Low confidence | Term ended | Term ended no later than Aug 26, 2017 | Low confidence |